Berberis asiatica: Potential fruits as nutrceuticals

International Journal of Pharmacy and Technology

Volumn 3, Issue 4, 2011, Pages 1586-1604

  Saklani, Sarla ^a   Chandra, Subhash ^a  

^a H N B GARHWAL UNIVERSITY   (India)

Author keywords

Anthocynins; Antioxidants; Berberis asiatica; Flavonoids; Nutraceuticals; Nutrients; Wild edible fruits

Indexed keywords

AMPICILLIN; ASCORBIC ACID; BERBAMINE; BERBERINE; BERBERINE SULFATE; BERBERIS ASIATICA EXTRACT; BERBERRUBIN; CANADINE; COLUMBAMINE; CORYTUBERINE; METFORMIN; NUTRACEUTICAL; OXYACANTHINE; OXYBERBERINE; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PROBERBERINE; PROTOBERBERINE; UNCLASSIFIED DRUG;

AMEBIASIS; AMNESIA; ANTIAMOEBIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPARASITIC ACTIVITY; ANTIPLATELET ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANTIPROTOZOAL ACTIVITY; ANTISECRETORY ACTIVITY; BERBERIS; BERBERIS ASIATICA; CARDIOVASCULAR ACTIVITY; CHOLINERGIC ACTIVITY; CONCENTRATION RESPONSE; DIABETES MELLITUS; DIURETIC ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFICACY; EDITORIAL; FRUIT; GASTROINTESTINAL ACTIVITY; GLIOSARCOMA; HEART ATRIUM FIBRILLATION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HEPATIC ACTIVITY; HYPERTENSION; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MUSCLE RELAXANT ACTIVITY; NONHUMAN; NUTRITIONAL VALUE; OSTEOPOROSIS; PAW EDEMA; PNEUMOCOCCAL INFECTION; SEDATION; SWELLING; VEIN THROMBOSIS;

EID: 84555218099     PISSN: None     EISSN: 0975766X     Source Type: Journal    
DOI: None     Document Type: Editorial

References (84)

1. Gaur R. D. 1999. Flora of the District Garhwal, North West Himalaya with Ethanobotanical Notes, Trans Media Publisher, Srinagar, Garhwal, India. 1st edn. 73.
2. Turner, N. J., Hebda R. J. Ethanopharmacol.1990, 29, 59-72.
3. Foster S, Tyler V. E. Tyler's Honest Herbal, 4 th ed. Binghamton, NY. Press, 1999.
4. Schauenberg P, Paris F. Guide to medicinal plants. New Canaan, CT, Keats Publising, Inc., 1977.
5. Duke J. A., Handbook of Medicinal Herbs, Boca Raton, FL: CRC Press 1985.
6. Hartwell JL. Lloydia 1968, 31:71.
7. Geiler U. Von der Weth A, Herger M. Ars Med. 1995, 14: 1018-1019.
8. Geiler U. Von der Weth A. Herger M. Ars Med. 1995, 31:31-34.
9. Bezakova L. Misic V. Malekova L. Pharmazie,1996, 51:758-761.
10. Wiesenauer, Ludtke, Phytomedicine 1996,3,231-235
11. Döpke W. Neue alkaloide aus Berberis vulgaris L. Naturwissenschaften 1963;50:595.
12. Di, D. L., Liu, Y. W., Ma, Z. G., and Jiang, S. X. Determination of four alkaloids in Berberis plants by HPLC. Zhongguo Zhong Yao Za Zhi 2003; 28(12):1132-1134.
13. Pozniakovskii, V. M., Golub, O. V., Popova, D. G., and Kovalevskaia, I. N. The use of barberry berries in human nutrition. Vopr Pitan 2003; 72(4):46-49. Parmar.
14. Parmar, C. and M.K. Kaushal. Berberis aristata. p. 10-14. In: Wild Fruits. Kalyani Publishers, New Delhi, India. 1982; 10-14.
15. Dutta NK and Iyer SN. Anti-amoebic value of berberine and kurchi alkaloids. Journal of the Indian Medical Association 1968; 50(8):349-354.
16. Supek Z and Tomic D. Farmakološko-kemijsko istrazivanje zutike Berberis vulgaris L.
17. Sabir M and Bhide NK. Study of some pharmacological actions of berberine. Ind J Physiol & Pharmac 1971; 15(3):111-132.
18. Chun YT, Yip TT, Lau KL, and et al. A biochemical study on the hypotensive effect of berberine in rats. Gen Pharmac 1979; 10:177-182.
19. Fukuda, K., Hibiya, Y., Mutoh, M., Koshiji, M., Akao, S., and Fujiwara, H. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol 1999;66(2):227-20.
20. Zhang, M. F. and Shen, Y. Q. Antidiarrheal and anti-inflammatory effects of berberine. Zhongguo Yao Li Xue Bao 1989; 10(2):174-176.
21. Ckless, K., Schlottfeldt, J. L., Pasqual, M., Moyna, P., Henriques, J. A., and Wajner, M. Inhibition of in-vitro lymphocyte transformation by the isoquinoline alkaloid berberine. J Pharm Pharmacol 1995; 47(12A):1029-1031.
22. Seow WK, Ferrante A, Summors A, and et al. Comparative effects of tetrandrine and berbamine on production of the inflammatory cytokines interleukin-1 and tumor necrosis factor. Life Sciences 1992; 50(8) pl-53-pl-58.
23. Hajnicka, V., Kost'alova, D., Svecova, D., Sochorova, R., Fuchsberger, N., and Toth, J. Effect of Mahonia aquifolium active compounds on interleukin-8 production in the human monocytic cell line THP-1. Planta Med 2002; 68(3):266-268.
24. Kost'alova, D., Kardosova, A., and Hajnicka, V. Effect of Mahonia aquifolium stem bark crude extract and one of its polysaccharide components on production of IL-8. Fitoterapia 2001; 72(7):802-806.
25. Ivanovska, N. and Philipov, S. Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. Int J Immunopharmacol 1996;18(10):553-561.
26. Freile, M. L., Giannini, F., Pucci, G., Sturniolo, A., Rodero, L., Pucci, O., Balzareti, V., and Enriz, R. D. Antimicrobial activity of aqueous extracts and of berberine isolated from Berberis heterophylla. Fitoterapia 2003; 74(7-8):702-705.
27. Mahajan VM, Sharma A, and Rattan A. Antimycotic activity of berberine sulphate: an alkaloid from an Indian medicinal herb. Sabouraudia 1982; 20:79-81.
28. Vollekova, A., Kostalova, D., and Sochorova, R. Isoquinoline alkaloids from Mahonia aquifolium stem bark are active against Malassezia spp. Folia Microbiol Praha 2001;46(2):107-111
29. Sabir M, Mahajan VM, Mohapatra LN, and et al. Experimental study of the antitrachoma action of berberine. Indian J Med Res 1976; 64(8):1160-1167.
30. Hashmi, K. and Hafiz, A. In vivo antibacterial activity of Berberis asiatica. J Pak Med Assoc 1986; 36(1):5-7.
31. Kaneda Y, Tanaka T, and Saw T. Effects of berberine, a plant alkaloid, on the growth of anaerobic protozoa in axenic culture. Tokai J Exp Clin Med 1990; 15(6):417-423.
32. Amin, A. H., Subbaiah, T. V., and Abbasi, K. M. Berberine sulfate: antimicrobial activity, bioassay, and mode of action. Can J Microbiol 1969; 15(9):1067-1076.
33. Chung JG, Wu LT, Chang SH, and et al. Inhibitory actions of berberine on growth and arylamine Nacetyltransferase activity in strains of Helicobacter Pylori from peptic ulcer patients. International Journal of Toxicology 1999; 18:35.
34. Hoshi, A., Ikekawa, T., Ikeda, Y., Shirakawa, S., and Iigo, M. Antitumor activity of berberrubine derivatives. Gann 1976; 67(2):321-325.
35. Chang, K. S., Gao, C., and Wang, L. C. Berberine-induced morphologic differentiation and down-regulation of c- Ki-ras2 protooncogene expression in human teratocarcinoma cells. Cancer Lett 12-3-1990; 55(2):103-108.
36. Krishnan, P. and Bastow, K. F. The 9-position in berberine analogs is an important determinant of DNA topoisomerase II inhibition. Anticancer Drug Des 2000; 15(4):255-264.
37. Sanders MM, Liu AA, Li TK, and et al. Selective cytotoxicity of topoisomerase-directed dprotoberberines against glioblastoma cells. Biochemical Pharmacology 1998; 56:1157-1166.
38. Miura N, Yamamoto M, Ueki T, and et al. Inhibition of thymocyte apoptosis by berberine. Biochemical Pharmacology 1997; 53:1315-1322.
39. Kumazawa Y, Itagaki A, Fukumoto M, and et al. Activation of peritoneal macrophages by berberine-type alkaloids in terms of induction of cytostatic activity. Int J Immunopharmac/ 1984; 6(6):587-592.
40. Zhang, R. X., Dougherty, D. V., and Rosenblum, M. L. Laboratory studies of berberine used alone and in combination with 1, 3-bis (2-chloroethyl)-1-nitrosourea to treat malignant brain tumors. Chin Med J (Engl) 1990; 103(8):658-665.
41. Nishino H, Kitagawa K, Fujiki H, and et al. Berberine sulfate inhibits tumor-promoting activity of teleocidin in two-stage carcinogenesis on mouse skin. Oncology 1986; 43:131-134.
42. Vik-Mo H, Faria DB, Cheung WM, and et al. Beneficial effects of berberine on left ventricular function in dogs with heart failure. Clinical Research 1983; 31(2):224a.
43. Li, T. K., Bathory, E., LaVoie, E. J., Srinivasan, A. R., Olson, W. K., Sauers, R. R., Liu, L. F., and Pilch, D. S. Human topoisomerase I poisoning by protoberberines: potential roles for both drug-DNA and drugenzyme interactions. Biochemistry 6-20-2000, 39(24):7107-7116.
44. Haisong J, Xiaojie L, Baolu Z, and et al. Scavenging effect of berbamine on active oxygen radicals in phorbol ester-stimulated human polymorphonuclear leukocytes. Biochemical Pharmacology 1990; 39(11):1673.
45. Misik, V., Bezakova, L., Malekova, L., and Kostalova, D. Lipoxygenase inhibition and antioxidant properties of protoberberine and aporphine alkaloids isolated from Mahonia aquifolium. Planta Med 1995; 61(4):372-373.
46. Ryzhikova, M. A., Farkhutdinov, R. R., Sibiriak, S. V., and Zagidullin, ShZ. [The effect of aqueous extracts of hepatotropic medicinal plants on free-radical oxidation processes]. Eksp Klin Farmakol 1999; 62(2):36-38.
47. Ghosh, A. K., Rakshit, M. M., and Ghosh, D. K. Effect of berberine chloride on Leishmania donovani. Indian J Med Res 1983; 78:407-416.
48. Wu, J. F. and Liu, T. P. [Effects of berberine on platelet aggregation and plasma levels of TXB2 and 6-keto-PGF1 alpha in rats with reversible middle cerebral artery occlusion]. Yao Xue Xue Bao 1995; 30(2):98-102.
49. Tripathi YB and Shukla SD. Berberis artistata inhibits PAF induced aggregation of rabbit platelets. Phytotherapy Research 1996; 10:628-630.
50. Kostalova, D., Bukovsky, M., Koscova, H., and Kardosova, A. [Anticomplement activity of Mahonia aquifolium bisbenzylisoquinoline alkaloids and berberine extract]. Ceska Slov Farm 2001; 50(6):286-289.
51. Xuan, B., Wang, W., and Li, D. X. Inhibitory effect of tetrahydroberberine on platelet aggregation and thrombosis. Zhongguo Yao Li Xue Bao 1994; 15(2):133-135.
52. Muller, K., Ziereis, K., and Gawlik, I. The antipsoriatic Mahonia aquifolium and its active constituents; II. Antiproliferative activity against cell growth of human keratinocytes. Planta Med 1995; 61(1):74-75.
53. Khin, Maung U. and Nwe, Nwe Wai. Effect of berberine on enterotoxin-induced intestinal fluid accumulation in rats. J Diarrhoeal Dis Res 1992; 10(4):201-204.
54. Sack, R. B. and Froehlich, J. L. Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins. Infect Immun 1982; 35(2):471-475.
55. Palmery M, Leone MG, Pimpinella G, and et al. Effects of Hydrastis canadensis L. and the two major alkaloids berberine and hydrastine on rabbit aorta. Pharmacological Research 1993; 27(suppl 1):73-74.
56. Shaffer, J. E. Inotropic and chronotropic activity of berberine on isolated guinea pig atria. J Cardiovasc Pharmacol 1985; 7(2):307-315.
57. Lau, C. W., Yao, X. Q., Chen, Z. Y., Ko, W. H., and Huang, Y. Cardiovascular actions of berberine. Cardiovasc Drug Rev 2001; 19(3):234-244.
58. Krol R, Zalewski A, Cheung W, and et al. Additive effects of berberine and ouabain on myocardial contractility. Clin Res 1982; 30(3):673A.
59. Krol R, Zalewski A, and Maroko PR. Beneficial effects of berberine, a new positive inotropic agent, on digitalis-induced ventricular arrhythmias. Circulation 1982; 66(suppl 2):56.
60. Ksiezycka E, Cheung W, and Maroko PR. Antiarrhythmic effects of berberine on aconitine-induced ventricular and supraventricular arrhythmias. Clinical Research 1983;31(2):197A
61. Huang, W. Ventricular tachyarrhythmias treated with berberine. Zhonghua Xin Xue Guan Bing Za Zhi 1990; 18(3):155-156, 190.
62. Gao, C. R., Zhang, J. Q., and Huang, Q. L. [Experimental study on berberin raised insulin sensitivity in insulin resistance rat models]. Zhongguo Zhong Xi Yi Jie He Za Zhi 1997;17(3):162-164.
63. Zalewski A, Krol R, and Maroko PR. Berberine, a new inotropic agent - distinction between its cardiac and peripheral responses. Clin Res 1983; 31(2):227A.
64. Zhou, J., Xuan, B., and Li, D. X. Effects of tetrahydroberberine on ischemic and reperfused myocardium in rats. Zhongguo Yao Li Xue Bao 1993; 14(2):130-133.
65. Peng, W. H., Hsieh, M. T., and Wu, C. R. Effect of long-term administration of berberine on scopolamineinduced amnesia in rats. Jpn J Pharmacol 1997; 74(3):261-266.
66. Akhter, M. H., Sabir, M., and Bhide, N. K. Possible mechanism of antidiarrhoeal effect of berberine. Indian J Med Res 1979; 70:233-241.
67. Zhang, M. F. and Shen, Y. Q. Antidiarrheal and anti-inflammatory effects of berberine. Zhongguo Yao Li Xue Bao 1989; 10(2):174-176.
68. Sack, R. B. and Froehlich, J. L. Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins. Infect Immun 1982; 35(2):471-475.
69. Swabb, E. A., Tai, Y. H., and Jordan, L. Reversal of cholera toxin-induced secretion in rat ileum by luminal berberine. Am J Physiol 1981; 241(3):G248-G252.
70. Chan, M. Y. The effect of berberine on bilirubin excretion in the rat. Comp Med East West 1977; 5(2):161-168.
71. Chan, E. Displacement of bilirubin from albumin by berberine. Biol Neonate 1993;63(4):201-208.
72. Gilani, A. H. and Janbaz, K. H. Prevention of acetaminophen-induced liver damage by Berberis aristata leaves. Biochem Soc Trans 1992; 20(4):347S.
73. Ni, Y. X. Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research.
74. Zhong Xi Yi, Jie Hea Zhi - Chinese Journal of Modern Developments in Traditional Medicine 1988;8(12):711
75. Gao, C. R., Zhang, J. Q., and Huang, Q. L. [Experimental study on berberin raised insulin sensitivity in insulin resistance rat models]. Zhongguo Zhong Xi Yi Jie He Za Zhi 1997; 17(3):162-164.
76. Luo C, Lin X, Li W, and et al. Study on the immunosuppressive effects of berbamine and its mechanism. Phytotherapy Research 1997; 11:585-587.
77. Li, S. Y., Ling, L. H., Teh, B. S., Seow, W. K., and Thong, Y. H. Anti-inflammatory and immunosuppressive properties of the bis- benzylisoquinolines: in vitro comparisons of tetrandrine and berbamine. Int J Immunopharmacol 1989; 11(4):395-401.
78. Kulkarni, S. K., Dandiya, P. C., and Varandani, N. L. Pharmacological investigations of berberine sulphate. Jpn J Pharmacol 1972;22
79. Huang W, Zhang Z, and Xu Y. Study of the effects and mechanisms of berberine on slow-response action potentials. Journal of Electrocardiology 1990; 23(3):231-234.
80. Li, H., Miyahara, T., Tezuka, Y., Namba, T., Suzuki, T., Dowaki, R., Watanabe, M., Nemoto, N., Tonami, S., Seto, H., and Kadota, S. The effect of kampo formulae on bone resorption in vitro and in vivo. II. Detailed study of berberine. Biol Pharm Bull 1999; 22(4):391-396.
81. Shanbhag, S. M., Kulkarni, H. J., and Gaitonde, B. B. Pharmacological actions of berberine on the central nervous system. Jpn J Pharmacol 1970; 20(4):482-487.
82. Swabb, E. A., Tai, Y. H., and Jordan, L. Reversal of cholera toxin-induced secretion in rat ileum by luminal berberine. Am J Physiol 1981; 241(3):G248-G252.
83. Di, D. L., Liu, Y. W., Ma, Z. G., and Jiang, S. X. 2003. Determination of four alkaloids in Berberis plants by HPLC. Zhongguo Zhong Yao Za Zhi; 28(12):1132-1134.
84. Pozniakovskii, V. M., Golub, O. V., Popova, D. G., and Kovalevskaia, I. N. 2003. The use of arberry berries in human nutrition. Vopr Pitan; 72(4):46-49.